Effect of long-term prophylactic treatment on survival after myocardial infarction
- 22 June 1984
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 76 (6), 76-83
- https://doi.org/10.1016/0002-9343(84)91047-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Secondary prevention after myocardial infarction: A review of short-term acute phase trialsProgress in Cardiovascular Diseases, 1983
- Secondary prevention after myocardial infarction: A review of long-term trialsProgress in Cardiovascular Diseases, 1982
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- A Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial InfarctionJAMA, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTIONThe Lancet, 1979
- Aspirin in coronary heart diseaseJournal of Chronic Diseases, 1976
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974
- Long-Term Anticoagulant Prophylaxis after Myocardial InfarctionNew England Journal of Medicine, 1969
- An Assessment of Long-term Anticoagulant Administration after Cardiac InarctionBMJ, 1964